MSF at the IAC
Poster Presentations
Monday, August 4 | Hall D
Tuesday, August 5 | Hall D
- Low level of virological failure and drug resistance among patients receiving antiretroviral treatment under programme conditions in Maputo, Mozambique [TUPE0353]
Abstract
Wednesday, August 6 | Hall D
Thursday, August 7 | Hall D
- Analysis of clinical, immunological outcomes of pediatric cohort of patients treated in Bulawayo, Zimbabwe [LBPE1155]
Poster
Abstract
- Early mortality (pre and post antiretroviral treatment) amongst children with HIV/AIDS enrolled in two programmes in Cambodia [THPE0101]
Abstract
- Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a programme setting in rural Cambodia [THPE0196]
Abstract
- Risk factors for hepatotoxicity of nevirapine-containing antiretroviral drug regimens in a large antiretroviral treatment programme in Rwanda [THPE0179]
Poster
Abstract
- Toxicity of stavudine- and nevirapine-containing antiretroviral treatment regimens: Incidence and risk factors after three years in a large cohort in Rwanda [THPE0188]
Poster
Abstract
- Weight evolution in patients after stavudine substitution for lipoatrophy in Rwanda: comparison of zidovudine with tenofovir/abacavir [THPE0149]
Poster
Abstract
Download all abstracts: